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The Answer, Of Course, Is Yes*Blase A. Carabello, MDI n this issue of iJACC, Petrov et al. (1) examinedpatterns of hypertrophy in patients with aorticstenosis. They found that women had “adap-
tive” hypertrophy more often than men, but when
women had “maladaptive” hypertrophy, their mor-
tality was increased, adding more proof of the sex
differences that exist in response to pressure over-
load (2). Obviously, the subject matter itself raises
the issue of what exactly is adaptive hypertrophy?SEE PAGE 1073The heart is a muscle, and all muscles have as their
basic purpose the ability to generate force. However,
unlike most other muscles in the body, the heart
must use the force it generates to propel its contents
(volume) forward. In ejecting adequate blood from
its chamber, it must have adequate chamber size to
fulﬁll the cardiac output needs of the body, and it
should also model itself in such a way as to
normalize systolic wall stress, the afterload opposing
ejection, because excess afterload impairs ejection
thereby reducing cardiac output. To be truly adap-
tive, the process should allow for normal cardiac
output, normal systolic and diastolic function, and
normal life span.
PHYSIOLOGIC HYPERTROPHY
Although modest myocyte division may occur
throughout life (3), it is generally held that most
myocytes are terminally differentiated shortly after
birth. Thus, most of the 10-fold increase in heart*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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disclose.size that must occur as the body grows from
infancy to adulthood occurs through hypertrophy,
a process whereby individual myocytes enlarge
instead of dividing. Not only is this physiologic
hypertrophy not pathologic, but it is necessary
for life. In addition, the heart appears to truly
adapt to the cardiac output needs of trained ath-
letes or to occupations that require increased
cardiac output (4,5). For instance, in isotonic aero-
bic exercise such as seen in long distance running,
eccentric hypertrophy allows for increased cardiac
output with concomitantly normal systolic and
diastolic function (5,6). Isometric exercise such as
weight lifting generates concentric hypertrophy also
associated with normal function (6). Thus, the mere
presence of hypertrophy by itself is not necessarily
deleterious.
HYPERTROPHY IN RESPONSE TO
HEMODYNAMIC OVERLOAD
Hemodynamic overload on the myocardium also
induces hypertrophy that is usually considered
compensatory at least in its early stages. However,
persistent severe overload eventually causes
myocardial damage, leading to systolic and diastolic
dysfunction, heart failure, and death. A presumed
key difference between physiologic and pathologic
hypertrophy is that conditions causing physiologic
hypertrophy are intermittent (the runner rests
between training sessions), whereas conditions
causing pathologic hypertrophy persistently load the
heart on every beat.
Four decades ago, Grossman et al. (7) hypothe-
sized that hypertrophy was driven by wall stress
where stress (s) ¼ (P  r)/(2  th), where P ¼
pressure, r ¼ radius, and th ¼ thickness. They
hypothesized that pressure overload increased sys-
tolic stress, causing additional sarcomeres to be laid
down in parallel, increasing myocyte thickness, and
leading to concentric hypertrophy. In this way,
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1082increased wall thickness in the denominator of the
Laplace equation offsets increased pressure in the
numerator, normalizing wall stress (afterload) and
maintaining normal ejection performance. Alter-
nately, volume overload increased diastolic stress,
leading to additional sarcomeres laid down in series,
thus elongating myocytes, and thereby increasing
chamber volume and stroke volume.
SO, IS HYPERTROPHY OCCURRING FROM
PRESSURE OVERLOAD GOOD OR BAD?
A reasonable way to address this question would be to
examine the outcomes in subjects where hypertrophy
does or does not occur in response to pressure over-
load and outcomes where hypertrophy is or is not
compensatory. Although this approach seems logical,
the results of such an examination are incredibly
confusing.
Esposito et al. (8) examined the results of pressure
overload in mice in which genetic alterations pre-
vented hypertrophy from occurring and compared
them to wild-type mice in which hypertrophy
occurred. Wall stress increased acutely (at 7 days) in
the altered mice, and ejection performance fell
modestly. However, at 8 weeks, mortality was similar
in both groups and LV function was reduced more in
the wild-type mice with LVH than in the genetically-
altered mice. Hill et al. (9) found similar results,
suggesting that LVH was not necessary for compen-
sation to occur. However, in 2 other mouse models,
the prevention of LVH led to cardiac decompensa-
tion and increased mortality (10,11). In humans with
aortic stenosis, Kupari et al. (12) found a greater
reduction in ejection fraction in patients with LVH
than in patients with concentric remodeling without
LVH. In the latter group, a small LV radius together
with increased relative wall thickness allowed for
stress normalization in the absence of increased
LV mass.
In the dog, as in man, the hypertrophic re-
sponse to a given pressure overload is variable. In a
model where the contractility of individual myo-
cytes could be studied, abundant hypertrophy that
normalized stress preserved myocyte contractile
function (13). However, when only modest hyper-
trophy developed, increased stress led to depressed
contractility of myocytes isolated from the left
ventricles.
Although it is hard to compare the adaptive deﬁ-
nition in the current study to the data from previous
works, it appears that adaptive LVH here is consistent
with smaller ventricular radius and increased relative
wall thickness that would normalize stress. Yet, thisis usually the geometry seen in patients with para-
doxic low ﬂow, low gradient AS, where mortality
seems higher than for typical aortic stenosis (14).
Further, in a study of propensity-matched pairs of AS
patients, those with concentric LVH had double the
mortality and morbidity than those without con-
centric LVH (15).
HOW CAN THESE APPARENT
CONTRADICTIONS BE RESOLVED?
First, some fundamental principles of ventricular
function are immutable. Ejection is regulated by
pre-load, afterload, and contractility. If afterload
increases, either pre-load, contractility, or both
must increase to maintain stroke volume and ejec-
tion performance. These mechanisms would be ex-
pected to lead to increased ﬁlling pressure and
oxygen consumption, respectively, both potentially
deleterious effects. Conversely, the presence of
enough LVH to normalize stress is almost inexorably
linked to diastolic dysfunction and impaired coro-
nary blood ﬂow reserve, also deleterious occur-
rences. Thus, there are negative consequences both
when afterload is or is not normalized, potentiating
adverse outcomes. And, ﬁnally, some patients
appear to do well despite LVH (or maybe because
of it).
The problem is that, on a patient-by-patient com-
parison, we are only examining gross morphology and
not the inner workings of the myocardium. It is highly
unlikely that a given relative wall thickness or mass
index imparts the same pathological myocardial
changes (or beneﬁcial ones) identically in all patients.
But, clinically, we are in effect judging each book by
its cover. Only when we begin to understand both the
histologic and physiologic changes that pressure
overload imparts on the speciﬁc patient of interest
will we begin to answer the question: is LVH good or
bad for that patient.
The work by Petrov et al. (1) emphasizes the wide
variation in left ventricular adaptation to the pressure
overload of aortic stenosis. Our challenge now is
to understand the relationships between these
morphologic changes and the biology underpinning
them, and then translating that knowledge into
prognosticating and improving patient outcomes.
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